KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Capital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

CRISPR Therapeutics AG (CRSP) Other Working Capital Changes (2016 - 2025)

Historic Other Working Capital Changes for CRISPR Therapeutics AG (CRSP) over the last 11 years, with Q3 2025 value amounting to -$834000.0.

  • CRISPR Therapeutics AG's Other Working Capital Changes fell 54361.7% to -$834000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was -$2.7 million, marking a year-over-year increase of 7641.66%. This contributed to the annual value of -$5.3 million for FY2024, which is 7723.85% up from last year.
  • According to the latest figures from Q3 2025, CRISPR Therapeutics AG's Other Working Capital Changes is -$834000.0, which was down 54361.7% from -$892000.0 recorded in Q2 2025.
  • In the past 5 years, CRISPR Therapeutics AG's Other Working Capital Changes ranged from a high of $9.3 million in Q3 2021 and a low of -$12.0 million during Q1 2023
  • Moreover, its 5-year median value for Other Working Capital Changes was -$834000.0 (2025), whereas its average is -$986315.8.
  • Per our database at Business Quant, CRISPR Therapeutics AG's Other Working Capital Changes surged by 21235.86% in 2022 and then tumbled by 54361.7% in 2025.
  • Quarter analysis of 5 years shows CRISPR Therapeutics AG's Other Working Capital Changes stood at -$4.9 million in 2021, then skyrocketed by 212.36% to $5.5 million in 2022, then crashed by 218.05% to -$6.4 million in 2023, then soared by 97.27% to -$176000.0 in 2024, then crashed by 373.86% to -$834000.0 in 2025.
  • Its Other Working Capital Changes was -$834000.0 in Q3 2025, compared to -$892000.0 in Q2 2025 and -$824000.0 in Q1 2025.